Buy This, Not That: Your Mid-Year “Magnificent 7” Investing Guide

They’re the titans of tech, the juggernauts of the market. Some are as sizzling as a summer heat wave… and others need to be put on ice. Find out which is which here…

Dealmaker’s Diary: This Biotech Is Fighting a Silent Killer

Chronic and life-threatening diseases are on the rise… But one company stands tall in the fight against a silent killer: pulmonary arterial hypertension.

Monday Takeaways: The Markets Are Fed Up

The markets are done listening to the Fed. That’s why investors need to pay attention to this corner of the market.

Buy This, Not That: Telecom Stocks Are Sending Mixed Signals

Telecom stocks can offer growth, value and even strong income. But not all telecoms are created equal…

Monday Takeaways: Incoming Big Tech Earnings Plus a Potentially Huge CPI Report

Wednesday’s CPI report could have a major impact on stocks. But there’s a lot more this week you should be watching…

Dealmaker’s Diary: Striking Gold in the Sunshine State

Real estate has been absolutely been battered this year… but that there’s opportunity as well. Like with this Florida-based realty company.

Buy This, Not That: Unboxing the Best (and Worst) Big Box Retailers

We’re diving deep into the world of big box retailers… to see which are riding high on AI and subscription services… and which are falling flat.

Dealmaker’s Diary: Unwrapping a Dividend Payer With Lots of Momentum

With all eyes on semiconductors and AI… it’s easy to overlook what seems mundane. But sometimes the most boring industries can deliver the most exciting returns.

Buy This, Not That: Will These Hotel Plays Heat Up for Summer?

We’re officially in the summer season… which means it’s time to dive into hotel stocks as vacation travel starts to heat up.

Dealmaker’s Diary: East Meets West With This Surprising Tech Play

This absolute behemoth of a tech stock is on the ropes. It tanked in 2021 and has been flat since. But it may be time for a breakout…